quantisnow
FeedTopReportsPricing
⌘K
Live feed
07:36:12·31d
SECFiling
Cabaletta Bio Inc. logo

SEC Form 10-K filed by Cabaletta Bio Inc.

CABA· Cabaletta Bio Inc.
Health Care
Full content unavailable. See the original source below.
Original source

Companies

  • CABA
    Cabaletta Bio Inc.
    Health Care

Recent analyst ratings

  • Oct 10UpdateJefferies$14.00
  • Dec 20UpdateEvercore ISI$6.00
  • Dec 19UpdateWells Fargo$6.00
  • Oct 10UpdateUBS$10.00
  • Feb 5UpdateJefferies$36.00
  • Nov 29UpdateWilliam Blair$38.00

Related

  • SEC3d
    Cabaletta Bio Inc. filed SEC Form 8-K: Other Events, Financial Statements and Exhibits
  • SEC6d
    SEC Form PRE 14A filed by Cabaletta Bio Inc.
  • PR9d
    First Patients Dosed with Cabaletta Bio's Rese-cel Manufactured on Cellares' Automated Cell Shuttle™ Platform
  • SEC31d
    SEC Form S-8 filed by Cabaletta Bio Inc.
  • SEC31d
    Cabaletta Bio Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Regulation FD Disclosure, Financial Statements and Exhibits
  • PR31d
    Cabaletta Bio Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update
  • INSIDER52d
    SEC Form 4 filed by Chief Business Officer Das Arun
  • INSIDER52d
    SEC Form 4 filed by General Counsel Gerard Michael
quantisnow

Real-time market intelligence for retail investors. Press releases, filings, ratings, and insider flow - all in one stream.

All systems operational

Feeds

Press releasesAnalyst ratingsInsider tradingFDASECRSS feeds

Top lists

TrendingBy market capActive companiesAnalyst upgradesInsider purchasesFDA approvalsSEC filingsSectorsMarket reports

Company

AboutPricingPublish with usContact

Legal

Terms of usePrivacy policyCookie policy

© 2026 quantisnow.com · Democratizing insights since 2022